We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Bevacizumab (recombinant humanised)
Australian Public Assessment Report
Device/Product Name
Avastin
Active ingredients
Bevacizumab (recombinant humanised)
AusPAR Date
Published
Sponsor
Submission Number
PM-2011-02308-3-4
Submission Type
Extension of indications
Decision
Approved